• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
    • Cardiovascular
    • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts & Webinars
    • Podcasts
    • Webinars
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech 100 Index
    • Videos
    • Whitepapers
  • DeviceTalks Tuesdays
  • Coronavirus: Live updates

Regulatory/Compliance

Abbott imaging catheter recall flagged as Class I by FDA

May 27, 2022 By Jim Hammerand

The FDA has identified the Abbott (NYSE:ABT) recall of its Dragonfly OpStar Imaging Catheter as a Class I recall. That’s the most serious level of a medical device recall, carrying the risk of serious injury or death. Five incidents, one injury and zero deaths were reported when Abbott initiated the recall on April 11. The […]

Filed Under: Blog, Cardiovascular, Catheters, Food & Drug Administration (FDA), Imaging, News Well, Recalls, Regulatory/Compliance, Vascular Tagged With: Abbott, FDA

DoMore Diagnostics wins CE mark for AI algorithm that predicts colorectal cancer outcomes

May 27, 2022 By Sean Whooley

DoMore Diagnostics announced that it received CE mark approval in Europe for its Histotype Px Colorectal deep learning algorithm. Oslo, Norway-based DoMore designed its Histotype Px Colorectal deep learning algorithm to predict colorectal cancer patient outcomes based on analysis of digital histology images. The company said in a news release that the algorithm, which builds […]

Filed Under: Diagnostics, Genomics/Molecular Diagnostics, Health Technology, Men's Health, Regulatory/Compliance, Software / IT Tagged With: CE Mark, DoMore Diagnostics

FDA grants IDE for MedAlliance’s sirolimus-eluting balloon

May 26, 2022 By Sean Whooley

MedAlliance announced today that it received FDA investigational device exemption (IDE) for its Selution SLR drug-eluting balloon. Geneva, Switzerland-based MedAlliance designed its Selution SLR (sustained limus release) novel sirolimus-eluting balloon to provide a controlled sustained drug release, similar to a drug-eluting stent. Get the full story at our sister site, Drug Delivery Business News.

Filed Under: Cardiovascular, Drug-Device Combinations, Drug-Eluting Stents, Food & Drug Administration (FDA), Regulatory/Compliance Tagged With: FDA, MedAlliance

Medtronic ‘hopeful’ on FDA clearance for next-gen diabetes tech in FY 2023

May 26, 2022 By Sean Whooley

The Medtronic (NYSE:MDT) diabetes business sputtered in the fourth quarter but could be bolstered by a major regulatory nod this year. The Fridley, Minnesota-based company saw revenues for its diabetes arm fall by 7.7% year-over-year in the fourth quarter amid overall misses on both sales and adjusted earnings per share compared to Wall Street’s expectations. […]

Filed Under: Business/Financial News, Diabetes, Drug Pumps, Drug-Device Combinations, Featured, Food & Drug Administration (FDA), MassDevice Earnings Roundup, Patient Monitoring, Regulatory/Compliance, Wall Street Beat Tagged With: Medtronic

Device developer SeaStar Medical hires chief medical officer

May 25, 2022 By Jim Hammerand

SeaStar Medical has hired Dr. Kevin Chung as chief medical officer of the medtech developer starting July 1. Denver-based SeaStar is developing a platform therapy focused on hyperinflammation of vital organs. The company’s Selective Cytopheretic Device was designated as a breakthrough device by the FDA earlier this year. SeaStar is set to go public in the […]

Filed Under: Blog, Blood Management, Business/Financial News, Dialysis, Food & Drug Administration (FDA), Mergers & Acquisitions, News Well, Regulatory/Compliance Tagged With: Brooke Army Medical Center, DARPA, Department of Defense, FDA, LMF Acquisition Opportunities, SeaStar Medical, Uniformed Services University, United States Army Institute of Surgical Research

inHeart wins FDA clearance for 3D cardiac modeling software

May 24, 2022 By Sean Whooley

inHeart announced today that it received FDA 510(k) clearance for its inHeart Models software suite for cardiac modeling. France-based inHeart designed its inHeart Models software to enable the 3D visualization and analysis of anatomical structures for pre-procedural planning and intraprocedural use. FDA clearance allows for the expansion of the company’s commercial footprint in the U.S. […]

Filed Under: 510(k), Cardiovascular, Food & Drug Administration (FDA), Health Technology, Imaging, Regulatory/Compliance, Software / IT Tagged With: FDA, inHeart

Anumana wins FDA breakthrough nod for AI algorithm that detects pulmonary hypertension

May 24, 2022 By Sean Whooley

Anumana announced today that it received FDA breakthrough device designation for its pulmonary hypertension (PH) early detection algorithm. Cambridge, Massachusetts-based Anumana, formed by Mayo Clinic and nference and launched in 2021, designed its AI-enhanced, electrocardiograph (ECG)-based PH early detection algorithm as a precise, non-invasive screening tool to provide earlier diagnosis for patients with PH that […]

Filed Under: Digital Health, Electronic Medical Records (EMR), Food & Drug Administration (FDA), Health Technology, Regulatory/Compliance, Software / IT, Vascular Tagged With: Anumana, Mayo Clinic, nference

FDA clears RapidAI’s pulmonary embolism triage platform

May 24, 2022 By Sean Whooley

RapidAI announced today that it received FDA 510(k) clearance for its Rapid PE Triage & Notification product. San Mateo, California-based RapidAI designed its Rapid PE Triage & Notification product for the fast identification and communication of suspected central pulmonary embolism (PE). According to a news release, Rapid PE Triage & Notification works in conjunction with […]

Filed Under: 510(k), Blood Management, Cardiovascular, Diagnostics, Digital Health, Food & Drug Administration (FDA), Health Technology, Regulatory/Compliance, Software / IT, Vascular Tagged With: FDA, RapidAI

Henry Schein investors push back on executive pay

May 23, 2022 By Jim Hammerand

Nearly half of Henry Schein (Nasdaq:HSIC) shareholders who voted at this month’s annual meeting voted against the company’s pay packages for top executives, according to a new SEC filing. About 48.5% of voting shareholders voted against the company’s executive pay plan in what’s known as the Say-on-Pay vote, according to vote results of the May 18 […]

Filed Under: Blog, Business/Financial News, Distribution, Featured, News Well, Regulatory/Compliance Tagged With: Henry Schein, SEC

Pfizer, BioNTech moving forward on seeking COVID-19 vaccine EUA for youngest children

May 23, 2022 By Sean Whooley

Pfizer (NYSE:PFE) and BioNTech (Nasdaq:BNTX) announced today that data support a three-dose primary series of their COVID-19 vaccine in young children Topline safety, immunogenicity and vaccine efficacy data from a Phase 2/3 trial evaluating a third 3-µg dose of the vaccine — marketed in the U.S. as Comirnaty — showed a strong immune response and […]

Filed Under: Business/Financial News, Clinical Trials, Featured, Food & Drug Administration (FDA), Pharmaceutical, Regulatory/Compliance Tagged With: BioNTech, coronavirus, COVID-19, Pfizer

FDA says Philips ventilator recall produced over 21,000 device reports, 124 deaths

May 20, 2022 By Sean Whooley

The FDA updated its communications on Philips‘ (NYSE:PHG) major ventilator recall with new data on device reports and patient deaths. In June 2021, Philips Respironics recalled millions of certain ventilators, bi-level positive airway pressure (BiPAP) and continuous positive airway pressure (CPAP) machines due to potential health risks caused by polyester-based polyurethane (PE-PUR) sound abatement foam […]

Filed Under: Business/Financial News, Featured, Food & Drug Administration (FDA), News Well, Recalls, Regulatory/Compliance, Respiratory Tagged With: Philips, Philips Respironics, Royal Philips

  • Go to page 1
  • Go to page 2
  • Go to page 3
  • Interim pages omitted …
  • Go to page 717
  • Go to Next Page »

Primary Sidebar

DeviceTalks Weekly

May 27, 2022
Quick message - No DTW podcast, but plenty else to listen to over this weekend and next week.
See More >

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World

Device Talks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our Device Talks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us
Add us on Facebook Follow us on Twitter Connect with us on LinkedIn Follow us on YouTube

Copyright © 2022 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS